Rationale and protocol for a randomized parallel intervention trial of two intermittent fasting approaches in

Felicia L Steger1, Joseph E Donnelly2, Robert N Montgomery3

  • 1Division of Endocrinology, Diabetes, and Clinical Pharmacology and KU Diabetes Institute; Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS, USA; Department of Dietetics and Nutrition, University of Kansas Medical Center, Kansas City, KS, USA; Kansas Center for Metabolism and Obesity Research, Kansas City, KS, USA.

PubMed
Summary

This study compares intermittent energy restriction (IER) and time-restricted eating (TRE) for type 2 diabetes (T2D) management. Results will guide personalized nutrition strategies for T2D patients with overweight or obesity.

Related Concept Videos

Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
143
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
861
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
677